A detailed history of Gagnon Securities LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Gagnon Securities LLC holds 1,437,722 shares of CDNA stock, worth $35.8 Million. This represents 9.47% of its overall portfolio holdings.

Number of Shares
1,437,722
Previous 2,174,167 33.87%
Holding current value
$35.8 Million
Previous $33.8 Million 32.94%
% of portfolio
9.47%
Previous 7.99%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$14.41 - $33.99 $10.6 Million - $25 Million
-736,445 Reduced 33.87%
1,437,722 $44.9 Million
Q2 2024

Aug 14, 2024

SELL
$7.56 - $16.15 $539,496 - $1.15 Million
-71,362 Reduced 3.18%
2,174,167 $33.8 Million
Q1 2024

May 13, 2024

BUY
$7.96 - $12.37 $1.19 Million - $1.85 Million
149,485 Added 7.13%
2,245,529 $23.8 Million
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $102,410 - $268,774
20,900 Added 1.01%
2,096,044 $25.2 Million
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $86,478 - $139,106
12,354 Added 0.6%
2,075,144 $14.5 Million
Q2 2023

Aug 08, 2023

BUY
$7.61 - $9.46 $372,714 - $463,322
48,977 Added 2.43%
2,062,790 $17.5 Million
Q1 2023

Apr 10, 2023

BUY
$8.83 - $17.61 $4.57 Million - $9.12 Million
518,067 Added 34.64%
2,013,813 $18.4 Million
Q4 2022

Feb 07, 2023

BUY
$10.88 - $20.05 $2.2 Million - $4.05 Million
202,136 Added 15.63%
1,495,746 $17.1 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $5.01 Million - $8.23 Million
311,813 Added 31.76%
1,293,610 $22 Million
Q2 2022

Aug 01, 2022

BUY
$20.49 - $39.72 $1.32 Million - $2.56 Million
64,577 Added 7.04%
981,797 $21.1 Million
Q1 2022

May 09, 2022

BUY
$28.19 - $46.6 $1.33 Million - $2.2 Million
47,203 Added 5.43%
917,220 $33.9 Million
Q4 2021

Feb 08, 2022

BUY
$41.2 - $73.6 $4.72 Million - $8.43 Million
114,520 Added 15.16%
870,017 $39.6 Million
Q3 2021

Nov 12, 2021

SELL
$59.15 - $91.99 $369,273 - $574,293
-6,243 Reduced 0.82%
755,497 $47.9 Million
Q2 2021

Jul 28, 2021

SELL
$63.02 - $95.11 $3.63 Million - $5.47 Million
-57,525 Reduced 7.02%
761,740 $69.7 Million
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $14.2 Million - $23.5 Million
-246,194 Reduced 23.11%
819,265 $55.8 Million
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $687,075 - $1.28 Million
-16,584 Reduced 1.53%
1,065,459 $77.2 Million
Q3 2020

Nov 12, 2020

SELL
$30.88 - $37.94 $33,906 - $41,658
-1,098 Reduced 0.1%
1,082,043 $41.1 Million
Q2 2020

Aug 13, 2020

SELL
$18.95 - $35.43 $493,306 - $922,313
-26,032 Reduced 2.35%
1,083,141 $38.4 Million
Q1 2020

May 11, 2020

BUY
$13.94 - $28.25 $1.69 Million - $3.42 Million
121,077 Added 12.25%
1,109,173 $24.2 Million
Q4 2019

Feb 14, 2020

BUY
$19.24 - $28.41 $568,618 - $839,629
29,554 Added 3.08%
988,096 $21.3 Million
Q3 2019

Nov 08, 2019

SELL
$20.03 - $40.08 $1.13 Million - $2.25 Million
-56,216 Reduced 5.54%
958,542 $21.7 Million
Q2 2019

Aug 12, 2019

SELL
$25.78 - $39.77 $2.06 Million - $3.17 Million
-79,759 Reduced 7.29%
1,014,758 $36.5 Million
Q1 2019

May 13, 2019

SELL
$22.09 - $39.21 $5.1 Million - $9.05 Million
-230,783 Reduced 17.41%
1,094,517 $34.5 Million
Q4 2018

Jan 18, 2019

SELL
$19.89 - $30.02 $4.84 Million - $7.3 Million
-243,255 Reduced 15.51%
1,325,300 $33.3 Million
Q3 2018

Nov 13, 2018

SELL
$12.1 - $28.85 $4.74 Million - $11.3 Million
-391,470 Reduced 19.97%
1,568,555 $45.3 Million
Q2 2018

Aug 09, 2018

BUY
$7.93 - $15.79 $1.35 Million - $2.69 Million
170,673 Added 9.54%
1,960,025 $24 Million
Q1 2018

May 09, 2018

SELL
$5.18 - $7.97 $463,060 - $712,470
-89,394 Reduced 4.76%
1,789,352 $14.3 Million
Q4 2017

Feb 13, 2018

SELL
$3.98 - $7.37 $1.14 Million - $2.12 Million
-287,657 Reduced 13.28%
1,878,746 $13.8 Million
Q3 2017

Nov 14, 2017

BUY
$1.33 - $4.12 $2.88 Million - $8.93 Million
2,166,403
2,166,403 $8.02 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.33B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.